[Clinical practice guidelines in gastrointestinal stromal tumours (GEIS): update 2008].
Poveda
Andrés
A
Servico de Oncología Médica, Fundación Instituto Valenciano de Oncología, Valencia, España. apoveda@fivo.org
Artigas
Vicenç
V
Casado
Antonio
A
Cervera
José
J
García Del Muro
Xavier
X
Antonio López-Guerrero
José
J
López-Pousa
Antonio
A
Maurel
Joan
J
Ortega
Luis
L
Ramos
Rafael
R
Romero
Ignacio
I
Safont
María José
MJ
Martín
Javier
J
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001549:Benzamides; D032921:Consensus; D003937:Diagnosis, Differential; D046152:Gastrointestinal Stromal Tumors / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000235:genetics / Q000601:surgery; D006801:Humans; D000068877:Imatinib Mesylate; D008279:Magnetic Resonance Imaging; D020360:Neoadjuvant Therapy; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use; D011379:Prognosis; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use; D012307:Risk Factors; D013997:Time Factors; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate